Vyvanse / Lisdexamfetamine → 🇫🇷 France

Full details

Vyvanse / Lisdexamfetamine restricted; documentation or permits may apply. Quantity guidance for France: Up to 1-month supply under Schengen personal-use exemption; ANSM approval may be required. Documentation: Schengen narcotics certificate from prescribing physician; Original prescription; Medication in original pharmacy-labelled packaging. Enforcement in France carries fines from EUR 250 to EUR 5,000 under Code des douanes Art. 411, Art. 412 (ordinary personal cases are handled as civil infringements). Restricted status means compliant carriage is achievable with the right paperwork and quantities; the practical risks are seizure, duty, and delay rather than criminal liability for a good-faith traveller. Arrival checks are carried out by Direction générale des douanes et droits indirects (DGDDI — French Customs); when in doubt use the declare (red) channel — declared goods at worst attract duty or surrender, while undeclared goods attract penalties. Leaving France with vyvanse / lisdexamfetamine is a separate question: restricted — Vyvanse (lisdexamfetamine) is a controlled stimulant; personal export from France requires prescription documentation and stays within personal-use limits.

Leaving France with vyvanse / lisdexamfetamine

Lisdexamfetamine is a Schedule II-equivalent controlled stimulant under the Code de la santé publique Art. R5132-74; Schengen Convention Art. 75 framework. Personal-use quantities (typically ≤30-90 days' supply) accompanied by the prescription and doctor's letter are generally permitted for export from France; above these limits a Schengen Article 75 certificate is required in advance. Destination-side treatment is the sharper risk — several countries (Japan requires advance permission; some jurisdictions ban amphetamine-class medicines outright) restrict arrival with stimulant ADHD medication, so verify the arrival rule for the same route.

OFFICIAL SOURCES · VERIFIED 2026-08-22